Can Thyroid Issues Cause Breast Pain?

Thyroid dysfunction can contribute to breast pain, and the link is better documented than most people realize. In studies of women presenting with breast pain (clinically called mastalgia), roughly one in five turns out to have an underactive thyroid. The connection runs through several hormonal pathways, and in many cases, treating the thyroid problem relieves the breast symptoms without any breast-specific therapy at all.

How Thyroid Dysfunction Reaches Breast Tissue

The thyroid gland does not sit near the breasts or share a direct nerve supply with them, so the connection is not obvious. It works through hormones that circulate in the blood and affect breast tissue indirectly. One of the most important routes involves a protein called sex hormone-binding globulin, or SHBG. This protein acts like a sponge for estrogen and testosterone, soaking up the hormones and keeping them inactive. Thyroid status has a strong influence on SHBG levels: an overactive thyroid drives SHBG up, while an underactive thyroid pushes it down.¹²

When SHBG drops because the thyroid is sluggish, more free estrogen circulates in the bloodstream. Breast tissue is packed with estrogen receptors, so it responds to that extra estrogen by swelling, retaining fluid, and becoming tender. This is the same basic mechanism behind the cyclical breast soreness many women feel before their periods, but hypothyroidism can amplify and prolong it. A second pathway involves prolactin. When thyroid hormone levels fall, the brain produces more thyrotropin-releasing hormone (TRH) in an attempt to stimulate the thyroid. TRH also stimulates prolactin release, and elevated prolactin independently promotes breast tenderness and engorgement. Some researchers view this prolactin pathway as the more direct trigger, since prolactin acts on breast tissue to encourage milk-duct activity even outside of pregnancy.

How Common Is Hypothyroidism Among Women with Breast Pain?

The overlap is surprisingly frequent. A study that screened women with benign breast disorders found that roughly 23% of those with mastalgia had hypothyroidism, compared to lower rates in the general population.³ Among women with nipple discharge, the rate was even higher at 37%. These numbers matter because thyroid testing is not a routine part of a breast-pain workup in many clinics. If you walk in complaining of sore breasts, you are more likely to get a mammogram or ultrasound than a thyroid blood test.

A separate evaluation of 100 women with mastalgia found that 18% had hypothyroidism, and most of those cases were subclinical, meaning the TSH level was elevated but the women had not been diagnosed or treated.⁴ The subclinical piece is important. These women had thyroid hormone levels that looked normal on a standard panel, but their TSH was quietly creeping upward. Their breast pain was real, and it had a treatable hormonal driver that nobody had caught.

Why Hypothyroidism Is the Bigger Concern

Both underactive and overactive thyroid states can affect the breasts, but hypothyroidism shows up far more often in breast-pain research. Part of the reason is simple epidemiology: hypothyroidism is much more common than hyperthyroidism in the general population, particularly among women of reproductive age. Autoimmune thyroiditis (Hashimoto’s disease) is the leading cause, and it tends to develop gradually, which means breast symptoms can appear long before the thyroid problem is diagnosed.

A study examining evening primrose oil for mastalgia found that overt hypothyroidism and Hashimoto’s thyroiditis were among the factors that made standard breast-pain treatment less effective. Women with these conditions did not respond well to the oil, but when their thyroid was treated with hormone replacement, the breast pain resolved.⁵ That finding underscores a practical point: if your breast pain is not responding to the usual remedies, an undetected thyroid issue could be the reason.

When Hyperthyroidism Causes Breast Symptoms

An overactive thyroid can also affect the breasts, though the picture looks different. The most dramatic reports involve Graves’ disease, the autoimmune form of hyperthyroidism. In a published case, a 27-year-old woman developed multiple breast masses with skin changes that were initially alarming enough to suggest malignancy. Biopsies showed only fat necrosis, and once her Graves’ disease was treated, the breast abnormalities resolved within months.⁶

Graves’ disease can also cause tender breast enlargement in men, a condition called gynecomastia. Clinicians first highlighted this association decades ago, noting tender breast swelling as a presenting symptom of hyperthyroidism in male patients. In the original case series, breast symptoms appeared before any thyroid treatment was started in some patients, ruling out medication as the cause. In every case, the breast tenderness went away once thyroid levels returned to normal.⁷ More recent case reports continue to document gynecomastia as a presenting sign of Graves’ disease, sometimes appearing as a unilateral breast mass.⁸

The mechanism in hyperthyroidism differs from the hypothyroid pathway. Excess thyroid hormone raises SHBG, which should theoretically lower free estrogen. But hyperthyroidism also increases overall estrogen production and speeds up the conversion of androgens to estrogens, so the net effect on breast tissue can still be stimulatory, particularly in men who have less estrogen to begin with.

Fibrocystic Breast Changes and Thyroid Disease

Breast pain often coexists with lumpy, nodular breast tissue, sometimes diagnosed as fibrocystic breast changes. This is not a disease in the traditional sense but rather a pattern of cysts, fibrosis, and swelling that can make breasts feel ropy, heavy, and painful. The overlap between fibrocystic changes and thyroid disease is well documented.

A meta-analysis found that hypothyroidism was associated with roughly double the odds of developing fibrocystic breast changes, though the confidence interval was wide enough that the result did not reach strict statistical significance.⁹ A study that compared women with thyroid nodules and Hashimoto’s thyroiditis to healthy controls painted a clearer picture: benign breast diseases were found in about 55% of women with nodular thyroid disease and 47% of those with Hashimoto’s, compared to 29% of women with no thyroid problems.¹⁰ Simple cysts were the most common finding, followed by fibrocystic changes and solid benign masses.

The practical takeaway is that if you have a thyroid condition, particularly an autoimmune one, you are more likely to develop benign breast changes that come with pain and lumpiness. That does not mean every lump is benign or that imaging can be skipped, but it does suggest that your thyroid history is relevant information for the clinician evaluating your breast symptoms.

What Happens When the Thyroid Is Treated

One of the most convincing pieces of evidence linking thyroid dysfunction to breast pain is how reliably the pain improves when the thyroid is corrected. In the study that found 23% hypothyroidism among women with mastalgia, 83% of the hypothyroid patients saw their breast symptoms improve with thyroid hormone replacement alone, with no additional breast-focused treatment.³ The outcomes for hypothyroid patients with mastalgia were actually significantly better than for women who had the same breast pain but normal thyroid function, presumably because the hypothyroid group had a specific correctable cause.

An earlier clinical series evaluated 19 patients with breast pain and fibrocystic disease who were treated with levothyroxine. About 73% experienced rapid pain relief, and nearly half achieved total resolution. Breast tissue softened and nodularity decreased within three months for many patients. Three women in the group had elevated prolactin levels before treatment; their prolactin normalized and their pain disappeared after thyroid replacement was started.¹¹ Those prolactin cases are a nice confirmation of the TRH-prolactin pathway described earlier. Fixing the thyroid brought TRH back down, which brought prolactin back down, which resolved the breast symptoms.

For hyperthyroid patients, the pattern is the same in reverse. The Graves’ disease cases described above all saw breast symptoms resolve once thyroid function was brought under control, whether through medication or other treatment. The breast changes themselves did not need separate surgical or medical intervention.

Breast and Thyroid Nodules Appearing Together

Beyond breast pain specifically, there is a broader pattern of breast and thyroid problems clustering in the same individuals. A cross-sectional study of over 12,000 participants found that people with thyroid nodules were about 19% more likely to also have breast masses, and the relationship was bidirectional: people with breast masses were similarly more likely to have thyroid nodules.¹² An earlier ultrasound-based study at a university hospital also documented frequent co-occurrence of breast and thyroid nodules in the same women.¹³

The reasons for this overlap are not entirely pinned down. Shared hormonal pathways are the leading explanation: both breast and thyroid tissue are sensitive to estrogen, and both respond to TSH-related signaling. Iodine also plays a role in both organs, and some researchers have speculated that iodine insufficiency could contribute to nodule formation in both sites. Autoimmune factors may be involved too, since autoimmune thyroid disease and certain benign breast conditions share immune-mediation pathways. Whatever the underlying explanation, the co-occurrence is frequent enough that some clinicians have advocated for thyroid screening in women with breast nodules and vice versa.

Thyroid Medications and Breast Side Effects

Sometimes the breast symptoms come not from the thyroid disease itself but from the medication used to treat it. Methimazole, an anti-thyroid drug commonly prescribed for hyperthyroidism, has been reported to cause breast swelling. In one case report, a 29-year-old man developed bilateral breast swelling just three days after starting methimazole, with symptoms worsening over time.¹⁴ Distinguishing drug-induced breast changes from the disease itself can be tricky, since Graves’ disease also causes gynecomastia on its own. The timing relative to medication start is the main clue.

On the levothyroxine side, the medication used to treat hypothyroidism, breast tenderness is occasionally listed among reported side effects, though it is uncommon at standard replacement doses. More often, levothyroxine resolves breast symptoms rather than causing them, as the treatment studies above showed. If you are on thyroid medication and develop new breast pain, it is worth flagging to your doctor so the dose and your thyroid levels can be reassessed. Overreplacement, where the dose tips you into a mildly hyperthyroid state, could theoretically trigger the same breast effects as true hyperthyroidism.

Other Common Causes of Breast Pain Worth Considering

Thyroid dysfunction is a real but underappreciated contributor to breast pain, yet most breast pain has nothing to do with the thyroid. A clinical review of breast pain identified two broad categories: cyclical pain, which is tied to the menstrual cycle and driven by fluctuating estrogen and progesterone, and noncyclical pain, which is independent of the cycle and can come from a wide range of causes including musculoskeletal problems, infections, poorly fitting bras, perimenopause, and prior surgery.¹⁵ Chest wall pain from costochondritis or muscle strain is frequently mistaken for breast pain, and it has nothing to do with hormones at all.

If you have breast pain that is persistent, does not follow the usual premenstrual pattern, or has not responded to standard treatments like evening primrose oil or a supportive bra, asking for a thyroid panel is a reasonable next step. A simple TSH test is cheap and widely available. If it comes back elevated, even mildly, you and your doctor have a concrete lead to pursue. Many women go through rounds of imaging and breast exams when the answer was sitting in their endocrine system the whole time.

Why Thyroid Testing Is Not Standard in Breast Pain Workups

Given the evidence, you might wonder why thyroid screening is not a routine part of evaluating breast pain. The short answer is that mastalgia guidelines in most countries focus on ruling out malignancy first, then managing symptoms with lifestyle changes and, if needed, hormonal drugs like tamoxifen or danazol. Thyroid function testing is not included in most published algorithms, partly because the strongest studies linking the two conditions come from single-center research rather than large multicenter trials, and partly because breast pain workups sit in surgical and radiology departments where thyroid expertise is not the primary focus.

The evidence is persuasive enough, though, that several research groups have called for thyroid screening to become standard in women presenting with mastalgia that does not respond to first-line treatments.¹⁶ Whether that recommendation gains traction in mainstream practice guidelines remains to be seen, but there is no downside to asking for a TSH test yourself. It is a low-cost, low-risk investigation that could point to a straightforward fix for a frustrating symptom.

Iron Deficiency as a Compounding Factor

One finding that tends to get overlooked is the role of iron. The same study that identified hypothyroidism and Hashimoto’s as barriers to effective mastalgia treatment also flagged iron deficiency as a significant factor. When iron-deficient women with breast pain received iron supplementation alongside thyroid treatment if needed, their mastalgia responded where it previously had not.⁵ Iron deficiency is common among premenopausal women due to menstrual blood loss, and it often coexists with hypothyroidism. If both conditions are present and neither is treated, breast pain may prove stubbornly resistant to the usual remedies. Addressing the thyroid alone might help, but catching the iron deficiency too can make the difference between partial and full relief.